In our trials, the plasma TSP-1 levels (29.01 ± 25.87 μg/mL vs 18.36 ± 10.89 μg/mL, p < 0.001) were significantly higher in patients with AA than patients without, which indicates patients with post-AMI AA, other than AF, may also need evaluation for potential risks of stroke and heart failure. The gene discussed is THBS1; the disease is stroke disorder.